In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Patpol and Patpol Legal at 8th International Congress of Family Businesses

It is estimated that over 90% of Polish companies are family businesses. How should a Czytaj dalej

Playing with WOŚP – With Heart and Sustainability

Every year, we proudly join forces with the Great Orchestra of Christmas Charity (WOŚP) – Czytaj dalej

Patpol’s patent attorneys at Packaging Innovations 2022!

It is already in the coming week when the next edition of Packaging Innovations trade Czytaj dalej